Application: Dispositif à système fermé transformant le lipoaspirat de tissu adipeux autologue en un produit injectable ou cryoconservable contenant des cellules souches dérivées du tissu adipeux (hADSC)
Norme de certification: Procédure à système fermé brevetée et standardisée, avec cycles de traitement programmables et kits jetables dédiés
Pays d'origine: Suisse

Autres informations

Description supplémentaire:

Theralip is an innovative therapeutic system that uses a purpose-built device to produce an injectable or cryopreservable tissue preparation from autologous adipose tissue globules containing adipose-derived stem cells (hADSCs), obtained via prior lipoaspiration. It offers an extensive catalog of disposable kits to maximize performance across different application areas, comprising a service unit (an electronic platform for automatically controlling the whole production process) and a sterile disposable kit (a preassembled sterile set with everything needed for the procedure). Treatment options include direct infusion, where the product is ready for immediate therapy right after processing, and cryopreservation, where the product is prepared for biobank storage.